Bailard’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-5,700
| Closed | -$264K | – | 621 |
|
|
2019
Q2 | $264K | Sell |
5,700
-15,500
| -73% | -$435K | 0.02% | 448 |
|
|
2019
Q1 | $517K | Sell |
21,200
-7,000
| -25% | -$146K | 0.03% | 287 |
|
|
2018
Q4 | $402K | Hold |
28,200
| – | – | 0.03% | 351 |
|
|
2018
Q3 | $429K | Hold |
28,200
| – | – | 0.03% | 407 |
|
|
2018
Q2 | $473K | Hold |
28,200
| – | – | 0.03% | 378 |
|
|
2018
Q1 | $460K | Hold |
28,200
| – | – | 0.03% | 336 |
|
|
2017
Q4 | $361K | Buy |
+28,200
| New | +$321K | 0.02% | 353 |
|
|
2015
Q4 | – | Sell |
-225,000
| Closed | -$1.03M | – | 388 |
|
|
2015
Q3 | $1.03M | Hold |
225,000
| – | – | 0.16% | 94 |
|
|
2015
Q2 | $1.62M | Hold |
225,000
| – | – | 0.25% | 73 |
|
|
2015
Q1 | $1.66M | Buy |
225,000
+120,000
| +114% | +$854K | 0.23% | 79 |
|
|
2014
Q4 | $497K | Hold |
105,000
| – | – | 0.07% | 149 |
|
|
2014
Q3 | $375K | Hold |
105,000
| – | – | 0.06% | 156 |
|
|
2014
Q2 | $479K | Hold |
105,000
| – | – | 0.07% | 134 |
|
|
2014
Q1 | $494K | Hold |
105,000
| – | – | 0.08% | 133 |
|
|
2013
Q4 | $526K | Sell |
105,000
-120,000
| -53% | -$653K | 0.08% | 133 |
|
|
2013
Q3 | $1.4M | Sell |
225,000
-100,000
| -31% | -$594K | 0.27% | 70 |
|
|
2013
Q2 | $1.48M | Buy |
+325,000
| New | +$1.75M | 0.27% | 78 |
|
Other funds holding ARRY
Bailard's ARRY Position: Q3 2019 in Review
Bailard sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 5,700 shares — an estimated $264K sold.
Bailard first reported a position in ARRY in Q2 2013 and held it in 17 quarters. The position peaked at $1.66M in Q1 2015. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- Bailard reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- Bailard sold 5,700 Array Biopharma Inc shares in Q3 2019, an estimated $264K.
- Bailard first reported a position in Array Biopharma Inc in Q2 2013 and held it in 17 quarters.
- Bailard's Array Biopharma Inc position peaked at $1.66M in Q1 2015.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on Bailard's 13F filing for Q3 2019, filed 18 Oct 2019.